Fibroblast proliferation and migration

Fibroblast proliferation and migration are integrated biological processes essential for physiological wound healing and tissue homeostasis. Upon tissue injury, fibroblasts are activated by growth factors such as Transforming Growth Factor-beta (TGF-β) and Platelet-Derived Growth Factor (PDGF), prompting them to migrate to the site of damage and proliferate to form a temporary scaffold (StatPearls, 2023). However, when these processes become chronic or dysregulated, they drive the progression of various fibrotic diseases, including idiopathic pulmonary fibrosis and systemic sclerosis, by causing excessive deposition of extracellular matrix (PubMed, 2021). In the context of oncology, cancer-associated fibroblasts (CAFs) exploit these mechanisms to create a supportive niche for tumor cells, facilitating invasion and immune evasion (Nature Reviews Cancer, 2020). Because "Fibroblast proliferation and migration" describes a complex cellular phenotype rather than a single molecular entity, therapeutic targeting focuses on specific receptors and signaling pathways that govern these behaviors (PubChem, 2024). Drugs like nintedanib and pirfenidone are currently utilized to slow disease progression by inhibiting the underlying kinase and cytokine signaling that fuels these fibroblast activities (NIH, 2022). Notable safety concerns for drugs targeting these pathways include impaired wound healing and gastrointestinal distress, reflecting the importance of these processes in normal tissue maintenance (PubMed, 2022).

Other names

Fibroblast activationMyofibroblast differentiationFibroblast-to-myofibroblast transitionWound healing response

Inhibition of receptor tyrosine kinases (such as PDGFR, FGFR, and VEGFR) or cytokine signaling (such as TGF-beta) to suppress the activation, expansion, and recruitment of fibroblast populations into injured or neoplastic tissues.